| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9084802 | REMPEX | Tetracycline compositions |
May, 2031
(7 years from now) | |
| US9278105 | REMPEX | Tetracycline compositions |
May, 2031
(7 years from now) | |
Minocin is owned by Rempex.
Minocin contains Minocycline Hydrochloride.
Minocin has a total of 2 drug patents out of which 0 drug patents have expired.
Minocin is available in injectable;injection dosage forms.
Minocin can be used as method of treating bacterial infections.
The generics of Minocin are possible to be released after 12 May, 2031.
Drugs and Companies using MINOCYCLINE HYDROCHLORIDE ingredient
Treatment: Method of treating bacterial infections
Dosage: INJECTABLE;INJECTION
How can I launch a generic of MINOCIN before it's drug patent expiration?
More Information on Dosage
MINOCIN family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic